Back to Search
GRANT LAMBRECHT, DMD
DMD
General Practice Dentistry
NPI: 1780416735Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
28450(MT)
Research & Publications (20)
Functional characterization of muscarinic autoreceptors in rat and human neocortex.
PMID 19493162·J Neurochem·2009
4-observational
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
PMID 18295023·Lancet·2008
4-observational
Severe bridging fibrosis of the colon in a man with inflammatory bowel disease.
PMID 17957610·Endoscopy·2007
5-case
The suramin analog 4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups.
PMID 16551782·Mol Pharmacol·2006
7-preclinical
The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.
PMID 16158305·Naunyn Schmiedebergs Arch Pharmacol·2005
4-observational
Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist.
PMID 15721178·Neuropharmacology·2005
4-observational
Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist.
PMID 15072843·Eur J Med Chem·2004
4-observational
NF449, a novel picomolar potency antagonist at human P2X1 receptors.
PMID 12787824·Eur J Pharmacol·2003
7-preclinical
Characterization of muscarinic autoreceptors in the rabbit hippocampus and caudate nucleus.
PMID 12675124·Neurochem Res·2003
7-preclinical
Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
PMID 12593665·J Med Chem·2003
7-preclinical
P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
PMID 12371966·Kidney Int·2002
7-preclinical
Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists.
PMID 12369951·Curr Pharm Des·2002
6-review
NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors.
PMID 11521173·Naunyn Schmiedebergs Arch Pharmacol·2001
7-preclinical
Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.
PMID 11354386·Bioorg Med Chem Lett·2001
8-other
Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications.
PMID 11111828·Naunyn Schmiedebergs Arch Pharmacol·2000
6-review
The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor.
PMID 10963748·Neuropharmacology·2000
7-preclinical
The novel heteromeric bivalent ligand SB9 potently antagonizes P2Y(1) receptor-mediated responses.
PMID 10869717·J Auton Nerv Syst·2000
7-preclinical
Functional role of muscarinic M(2) receptors in alpha,beta-methylene ATP induced, neurogenic contractions in guinea-pig ileum.
PMID 10742302·Br J Pharmacol·2000
7-preclinical
Muscarinic properties of compounds related to arecaidine propargyl ester.
PMID 10683710·Arzneimittelforschung·2000
7-preclinical
The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptors.
PMID 10650184·Eur J Pharmacol·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 16332 BECKWITH ST
FRENCHTOWN, MT 59834 - Phone
- (406) 626-4337
Quick Facts
- NPI
- 1780416735
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile